The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Vigabatrin Versus ACTH as First‐Line Treatment for Infantile Spasms: A Randomized, Prospective Study
Open accessAbstract
Summary: Purpose: To compare the efficacy and tolerability of vigabatrin (VGB) and adrenocorticotrophic hormone (ACTH) as first‐line therapy in infantile spasms. Methods: Forty‐two infants (22 males, 20 females) aged 2–9 months with newly diagnosed infantile spasms, were included in the trial. Patients were randomized to receive VGB 100–150 mg/kg/day or Depot ACTH 10 IU/day. The alternative drug was given if spasms were not controlled within 20 days or in cases of intolerance to initial therapy. Twenty‐three patients (7 cryptogenic, 16 symptomatic) received VGB as first‐line therapy; 19 patients (8 cryptogenic, 11 symptomatic) received ACTH as the first drug. Results: Cessation of spasms was observed in 11 (48%) of the patients randomized to VGB and in 14 (74%) of those randomized to ACTH. Response to VGB was observed within 1–14 days, but two‐thirds of patients (7/11) responded within 3 days. In the group treated with VGB, side effects such as drowsiness, hypotonia and irritability were observed in 13% of patients, compared with 37% in the group treated with ACTH. VGB was more effective than ACTH as treatment for cerebral malformations or tuberous sclerosis, whereas ACTH proved more effective in perinatal hypoxic/ischemic injury. The efficacy of the two drugs was similar in cryptogenic cases. Disappearance of interictal EEG abnormalities occurred sooner in patients randomized to ACTH than in those who received VGB as initial therapy. During the second phase, the alternative drug was given to the resistant patients. Spasms ceased in 2 of 5 patients treated with VGB and in 11 of 12 patients treated with ACTH. After 3 months, relapses of spasms were observed in 6 patients treated with ACTH and in 1 treated with VGB. VGB produced a therapeutic response in nearly half the patients receiving this drug. Conclusions: Our data lend further support to the view that VGB may be considered a first‐choice drug in the treatment of IS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Therapeutic Trial of Vigabatrin in Refractory Infantile Spasms
Chiron, C., Dulac, O., Beaumont, D., Palacios, L., Pajot, N., & Mumford, J. (1991) · Journal of Child Neurology · doi:10.1177/0883073891006002101 · Cited by 235
Vigabatrin as Initial Therapy for Infantile Spasms: A European Retrospective Survey
Aicardi, J. F., Groups, S. I. I. A. P. R., Mumford, J. P., Dumas, C. M., & Wood, S. M. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00627.x · Cited by 187
Dreifuss, F. E. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520110007005 · Cited by 86
Robertson, M. M. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb05730.x · Cited by 86
Benzodiazepines in the Treatment of Children with Epilepsy
Farrello, K. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb05733.x · Cited by 75
Rett syndrome: Epidemiology and nosology — progress in knowledge 1986 — A conference communication
Hagberg, B. A., & Witt‐Engerström, I. (1987) · Brain and Development · doi:10.1016/s0387-7604(87)80062-1 · Cited by 64
Cited by
Guerrini, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68182-8 · Cited by 848
Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma
Löscher, W., & Schmidt, D. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03024.x · Cited by 590
Mackay, M. T., Weiss, S. K., Adams-Webber, T., Ashwal, S., Stephens, D., Ballaban-Gill, K., Baram, T. Z., Duchowny, M., Hirtz, D., Pellock, J. M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000127773.72699.c8 · Cited by 401
Neuro‐epileptic determinants of autism spectrum disorders in tuberous sclerosis complex
Bolton, P. F., Park, R. J., Higgins, J. N. P., Griffiths, P. D., & Pickles, A. (2002) · Brain · doi:10.1093/brain/awf124 · Cited by 300
(2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52898-8.00004-5 · Cited by 40
Metadata
- Authors
- Vigevano, P., & Cilio, M. R.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 1997-12
- Volume
- 38
- Issue
- 12
- Pages
- 1270-1274
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2050910356
- Cited by
- 269
- References
- 7
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vigabatrin Versus ACTH as First‐Line Treatment for Infantile Spasms: A Randomized, Prospective Study. https://app.cochat.ai/papers/10.1111/j.1528-1157.1997.tb00063.x
- The paper
- Vigevano, P., & Cilio, M. R. (1997). Vigabatrin Versus ACTH as First‐Line Treatment for Infantile Spasms: A Randomized, Prospective Study. Epilepsia. https://doi.org/10.1111/j.1528-1157.1997.tb00063.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.